Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Liabilities ₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr₹13,229 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹13,309 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr
Mar2021₹14,069 Cr
Mar2020₹13,229 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr
9.44
Mar2021 ₹14,069 Cr
6.35
Mar2020 ₹13,229 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,265.6 Cr -5.4% -11.9% 19.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,195.0 Cr -0.3% -3.4% -6.9% Stock Analytics
DIVIS LABORATORIES ₹159,417.0 Cr -1.6% -10.2% 30.3% Stock Analytics
CIPLA ₹124,867.0 Cr -1% 4.8% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,971.0 Cr 1.2% 3.9% 9% Stock Analytics
DR REDDYS LABORATORIES ₹103,956.0 Cr -0.6% -1.1% -9.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-5.4%

-11.9%

19.2%

SENSEX

2%

0.1%

1.8%


You may also like the below Video Courses